Skip to main content

and
  1. Article

    Open Access

    FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

    Yannan Jia, Weiguo Zhang, Mahesh Basyal, Kyung Hee Chang, Lauren Ostermann in Leukemia (2023)

  2. Article

    Open Access

    Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy

    Barbara Muz, Feda Azab, Mark Fiala, Justin King, Daniel Kohnen in Blood Cancer Journal (2019)

  3. Article

    Open Access

    Disease modifying and antiangiogenic activity of 2-Methoxyestradiol in a murine model of rheumatoid arthritis

    A critical component of disease progression in rheumatoid arthritis (RA) involves neovascularization associated with pannus formation. 2-methoxyestradiol (2ME2) is a naturally occurring molecule with no known ...

    Stacy M Plum, Eun J Park, Steve J Strawn in BMC Musculoskeletal Disorders (2009)

  4. Article

    Open Access

    ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo

    Hepatocellular carcinoma (HCC) represents a highly vascularized tumor entity and the process of angiogenesis is essential for the growth of HCC. Importantly, the pro-angiogenic transcription factors HIF-1α and...

    Christian Moser, Sven A Lang, Akira Mori, Claus Hellerbrand, Hans J Schlitt in BMC Cancer (2008)

  5. No Access

    Article

    Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells

    Using a nonviral, electroporation-based gene transfection approach, we demonstrate the efficient and consistent transfection of two poorly immunogenic tumor cell lines: B16F10 melanoma and renal carcinoma (REN...

    Jonathan M Weiss, Rama Shivakumar, Stephanie Feller, Lin-Hong Li in Cancer Gene Therapy (2004)

  6. No Access

    Article

    Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile

    Endostatin, a potent endogenous inhibitor of angiogenesis, inhibits the growth of primary tumors without induction of acquired drug resistance in mice. We report that a soluble recombinant human (rh) Endostati...

    B. Kim Lee Sim, William E. Fogler, **n Hua Zhou, Hong Liang, John W. Madsen in Angiogenesis (1999)

  7. No Access

    Article

    Biological characterization of a chimeric mouse-human IgM antibody directed against the 17-1A antigen

    A chimeric antibody was constructed in which the murine H- and L-chain variable regions of mAb 17-1A, raised against human colorectal cancer cells, were joined with the human constant μ and κ regions. Transfec...

    William E. Fogler, Lee K. Sun, Mark R. Klinger in Cancer Immunology, Immunotherapy (1989)

  8. No Access

    Chapter

    Circumvention of Neoplastic Heterogeneity by Systemically Activated Macrophages

    The continuous growth of metastases that are resistant to conventional therapies is the major cause of death from colorectal carcinoma. Recent data indicate that metastases can arise from the nonrandom spread ...

    Isaiah J. Fidler, J. Milburn Jessup in Biology and Treatment of Colorectal Cancer… (1986)

  9. No Access

    Article

    Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon

    Human recombinant gamma interferon (INF-γ) activated human peripheral blood monocytes to a cytotoxic state capable of lysing adherent tumorigenic cells without harming normal cells. The efficiency of INF-γ act...

    Wayne C. Koff, William E. Fogler, Jordan Gutterman in Cancer Immunology, Immunotherapy (1985)

  10. No Access

    Chapter

    Role of Macrophages in Host Resistance Against Tumors

    The most devastating aspect of cancer is the propensity of malignant neoplasms to spread from their primary site of growth to distant organs where secondary tumors, metastases, can develop. Despite remarkable ...

    William E. Fogler, Isaiah J. Fidler in Basic and Clinical Tumor Immunology (1983)

  11. No Access

    Article

    Toxicity studies of liposome-encapsulated immunomodulators administered intravenously to dogs and mice

    Multilamellar liposomes containing lymphokines from mitogen-stimulated rat lymphocytes were injected IV into BALB/c or (C57BL/6×C3H)F1 mice and Beagle dogs to evaluate their potential toxicity. Animals receive...

    Ian R. Hart, William E. Fogler, George Poste in Cancer Immunology, Immunotherapy (1981)